Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Hoffmann

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
AIDS (London, England)|September 27, 2014
The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patientsStéphanie Bibert, Agnieszka Wojtowicz, Patrick Taffé, et al.
Acta Dermato-Venereologica|April 23, 2025
Photoaging and Cosmetic Result with Artificial Daylight Photo-dynamic Therapy Using Methyl AminolevulinateRolf-Markus Szeimies, Matthias Brückner, Matthias Hoffmann, et al.
Plos One|April 6, 2012
Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomesLukas Fenner, Sebastien Gagneux, Jean-Paul Janssens, et al.
The British Journal of Dermatology|November 7, 2024
Artificial daylight photodynamic therapy using methyl aminolaevulinate in a real-world setting in Germany: results from the noninterventional study ArtLightWolfgang G Philipp-Dormston, Matthias Brückner, Matthias Hoffmann, et al.
International Archives of Allergy and Immunology|February 5, 2011
Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract--a new therapeutic option for patients with atopic dermatitisNatalija Novak, Diamant Thaci, Matthias Hoffmann, et al.
Infectious Agents and Cancer|April 18, 2021
Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin's lymphomaChristina K S Muller, Julian Spagnuolo, Annette Audigé, et al.
Open Forum Infectious Diseases|October 14, 2017
Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort StudyCornelia Bayard, Bruno Ledergerber, Markus Flepp, et al.
The Biochemical Journal|October 17, 2006
BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivoGopal P Sapkota, Lorna Cummings, Felicity S Newell, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|April 11, 2013
Potential role of telemedical service centers in managing remote monitoring data transmitted daily by cardiac implantable electronic devices: results of the early detection of cardiovascular events in device patients with heart failure (detecT-Pilot) studyAxel Müller, Andreas Goette, Christian Perings, et al.
Journal of Medicinal Chemistry|February 6, 2018
Structure-Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo ProfilesDominik Dolles, Matthias Hoffmann, Sandra Gunesch, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
AIDS (London, England)|September 27, 2014
The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patientsStéphanie Bibert, Agnieszka Wojtowicz, Patrick Taffé, et al.
Acta Dermato-Venereologica|April 23, 2025
Photoaging and Cosmetic Result with Artificial Daylight Photo-dynamic Therapy Using Methyl AminolevulinateRolf-Markus Szeimies, Matthias Brückner, Matthias Hoffmann, et al.
Plos One|April 6, 2012
Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomesLukas Fenner, Sebastien Gagneux, Jean-Paul Janssens, et al.
The British Journal of Dermatology|November 7, 2024
Artificial daylight photodynamic therapy using methyl aminolaevulinate in a real-world setting in Germany: results from the noninterventional study ArtLightWolfgang G Philipp-Dormston, Matthias Brückner, Matthias Hoffmann, et al.
International Archives of Allergy and Immunology|February 5, 2011
Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract--a new therapeutic option for patients with atopic dermatitisNatalija Novak, Diamant Thaci, Matthias Hoffmann, et al.
Infectious Agents and Cancer|April 18, 2021
Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin's lymphomaChristina K S Muller, Julian Spagnuolo, Annette Audigé, et al.
Open Forum Infectious Diseases|October 14, 2017
Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort StudyCornelia Bayard, Bruno Ledergerber, Markus Flepp, et al.
The Biochemical Journal|October 17, 2006
BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivoGopal P Sapkota, Lorna Cummings, Felicity S Newell, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|April 11, 2013
Potential role of telemedical service centers in managing remote monitoring data transmitted daily by cardiac implantable electronic devices: results of the early detection of cardiovascular events in device patients with heart failure (detecT-Pilot) studyAxel Müller, Andreas Goette, Christian Perings, et al.
Journal of Medicinal Chemistry|February 6, 2018
Structure-Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo ProfilesDominik Dolles, Matthias Hoffmann, Sandra Gunesch, et al.
Pageof 15